Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-26 · accession 0001193125-26-083586 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-02-27 | 2026-02-26 | AXSM | Jacobson Mark L. | COO | M - OptEx | $2.85 | +35.4K | 35.4K | New | +$100.8K |
| DT | 2026-02-27 | 2026-02-26 | AXSM | Jacobson Mark L. | COO | S - Sale+OE | $161.88 | -35.4K | 0 | -100% | -$5.73M |
| DT | 2026-02-27 | 2026-02-26 | AXSM | Jacobson Mark L. | COO | M - OptEx | $0.00 | -35.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | M | A | 35,378 | $2.85 | 35,378 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-26 | S | D | 35,378 | $161.88 | 0 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $160.10 and $163.42. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-02-26 | M | D | 35,378 | $0.00 | 0 | D | $2.85 · 2019-03-12 to 2028-03-12 | 35,378 Common Stock |